The logo of Bayer is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany, Feb 24, 2014.
Operating, or underlying profit before special items grew 2.8% to 9.5 billion euros, while revenues rose 4.5% to reach 39.6 billion, adjusting for price and currency effects. A first federal case got underway this week, also in California, one of seven trials scheduled for this year. At the moment blockbuster drugs, including anticoagulant Xarelto or cancer treatments Stivarga and Xofigo, bring in 6.8 billion euros of revenue a year.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
منبع: msianinsight - 🏆 8. / 63 ادامه مطلب »
منبع: malaymail - 🏆 1. / 86 ادامه مطلب »